Budgetary Impact Of Intravitreal Aflibercept Injection (IAI) In Treating Neovascular Age-Related Macular Degeneration In A US Health Plan Of Adults Ages 65 Years And Older

May 1, 2013, 00:00
10.1016/j.jval.2013.03.884
https://www.valueinhealthjournal.com/article/S1098-3015(13)00955-8/fulltext
Title : Budgetary Impact Of Intravitreal Aflibercept Injection (IAI) In Treating Neovascular Age-Related Macular Degeneration In A US Health Plan Of Adults Ages 65 Years And Older
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00955-8&doi=10.1016/j.jval.2013.03.884
First page : A176
Section Title : Sensory Systems Disorders
Open access? : No
Section Order : 433
Categories :
Tags :
Regions :
ViH Article Tags :